alovudine has been researched along with Lymphoma, Large B-Cell, Diffuse in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chmielowska, E; Kuliczkowski, K; Małkowski, B; Olejniczak, M; Rybka, J; Sokołowska, E; Wróbel, T | 1 |
| Bhattacharya, A; Biswal, CK; Mittal, BR; Prabhakar, S; Shukla, J; Vatsa, R | 1 |
| Gavane, S; Grewal, R; Hamlin, P; Horwitz, S; Larson, SM; Matasar, M; Migliacci, JC; Moskowitz, A; Moskowitz, CH; Noy, A; Palomba, L; Portlock, C; Schöder, H; Straus, D; Zelenetz, AD | 1 |
| Buck, AK; Dechow, T; Graf, N; Herrmann, K; Junger, A; Keller, U; Ringshausen, I; Rudelius, M; Schuster, T; Schwaiger, M; Wester, HJ; Wieder, HA | 1 |
| Chacko, G; Epstein, R; Fung, KM; Gumerlock, MK; Holter, JL; Kedzierska, K; Smith, ML; Swisher, K; Thorp, K | 1 |
| Aichler, M; Buck, AK; Dechow, T; Feuchtinger, A; Graf, N; Herrmann, K; Keller, U; Numberger, B; Peschel, C; Schuster, T; Schwaiger, M; Senekowitsch-Schmidtke, R; Wester, HJ; Zwisler, D | 1 |
2 trial(s) available for alovudine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma.
Topics: Adult; Aged; Dideoxynucleosides; Disease-Free Survival; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Time Factors; Treatment Outcome; Young Adult | 2016 |
Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Cell Proliferation; Cyclophosphamide; Dideoxynucleosides; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prognosis; Survival Analysis; Treatment Outcome; Vincristine | 2011 |
4 other study(ies) available for alovudine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Comparing radioactive tracers 18F-FDG and 18F-FLT in the staging of diffuse large B-cell lymphoma by PET/CT examination: A single-center prospective study.
Topics: Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radioactive Tracers; Radiopharmaceuticals | 2019 |
Fluorothymidine PET/CT in neurolymphomatosis.
Topics: Animals; Biopsy; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Marek Disease; Middle Aged; Multimodal Imaging; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sciatic Neuropathy; Tomography, X-Ray Computed | 2015 |
[18F]fluorothymidine PET imaging in the diagnosis of leptomeningeal involvement with diffuse large B-cell lymphoma.
Topics: Dideoxynucleosides; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Meningeal Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
[18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner.
Topics: Animals; Antibiotics, Antineoplastic; Caspase 3; Cell Proliferation; Dideoxynucleosides; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, SCID; Neoplasm Staging; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Transplantation, Heterologous | 2013 |